Precursor forms of Vitamin D reduce HIV-1 infection in vitro
ABSTRACT: Background: Although the anti-HIV-1 effects of vitamin D (VitD) have been reported, mechanisms behind such protection remain largely unexplored. Methods: The effects of two precursor forms (cholecalciferol/calciol at 0.01, 1 and 100 nM and calcidiol at 100 and 250 nM) on HIV-1 infection, i...
- Autores:
-
Aguilar Jiménez, Wbeimar
Villegas Ospina, Simón
González Díaz, Sandra Milena
Zapata Builes, Wildeman
Saulle, Irma
Garziano, Micaela
Biasin, Mara
Clerici, Mario
Rugeles López, María Teresa
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2016
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/29861
- Acceso en línea:
- https://hdl.handle.net/10495/29861
- Palabra clave:
- VIH-1
HIV-1
ADP-Ribosil Ciclasa 1
ADP-ribosyl Cyclase 1
Vitamina D
Vitamin D
Linfocitos T
T-Lymphocytes
Antígenos HLA-DR
HLA-DR Antigens
CD38
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id |
UDEA2_c84bc8d5f2f791e5a50c218b55b1c452 |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/29861 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
title |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
spellingShingle |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro VIH-1 HIV-1 ADP-Ribosil Ciclasa 1 ADP-ribosyl Cyclase 1 Vitamina D Vitamin D Linfocitos T T-Lymphocytes Antígenos HLA-DR HLA-DR Antigens CD38 |
title_short |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
title_full |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
title_fullStr |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
title_full_unstemmed |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
title_sort |
Precursor forms of Vitamin D reduce HIV-1 infection in vitro |
dc.creator.fl_str_mv |
Aguilar Jiménez, Wbeimar Villegas Ospina, Simón González Díaz, Sandra Milena Zapata Builes, Wildeman Saulle, Irma Garziano, Micaela Biasin, Mara Clerici, Mario Rugeles López, María Teresa |
dc.contributor.author.none.fl_str_mv |
Aguilar Jiménez, Wbeimar Villegas Ospina, Simón González Díaz, Sandra Milena Zapata Builes, Wildeman Saulle, Irma Garziano, Micaela Biasin, Mara Clerici, Mario Rugeles López, María Teresa |
dc.subject.decs.none.fl_str_mv |
VIH-1 HIV-1 ADP-Ribosil Ciclasa 1 ADP-ribosyl Cyclase 1 Vitamina D Vitamin D Linfocitos T T-Lymphocytes Antígenos HLA-DR HLA-DR Antigens |
topic |
VIH-1 HIV-1 ADP-Ribosil Ciclasa 1 ADP-ribosyl Cyclase 1 Vitamina D Vitamin D Linfocitos T T-Lymphocytes Antígenos HLA-DR HLA-DR Antigens CD38 |
dc.subject.proposal.spa.fl_str_mv |
CD38 |
description |
ABSTRACT: Background: Although the anti-HIV-1 effects of vitamin D (VitD) have been reported, mechanisms behind such protection remain largely unexplored. Methods: The effects of two precursor forms (cholecalciferol/calciol at 0.01, 1 and 100 nM and calcidiol at 100 and 250 nM) on HIV-1 infection, immune activation, and gene expression were analyzed in vitro in cells of Colombian and Italian healthy donors. We quantified levels of released p24 by enzyme-linked immunosorbent assay, of intracellular p24 and cell-surface expression of CD38 and HLA-DR by flow cytometry, and mRNA expression of antiviral and immunoregulatory genes by real-time reverse transcription-polymerase chain reaction. Results: Cholecalciferol decreased the frequency of HIV-1-infected p24CD4 T cells and levels of p24 in supernatants in a dose-dependent manner. Moreover, the CD4CD38HLA-DR and CD4CD38HLA-DR subpopulations were more susceptible to infection but displayed the greatest cholecalciferol-induced decreases in infection rate by an X4-tropic strain. Likewise, cholecalciferol at its highest concentration decreased the frequency of CD38HLA-DR but not of CD38HLA-DR T-cell subsets. Analyzing the effects of calcidiol, the main VitD source for immune cells and an R5-tropic strain as the most frequently transmitted virus, a reduction in HIV-1 productive infection was also observed. In addition, an increase in mRNA expression of APOBEC3G and PI3 and a reduction of TRIM22 and CCR5 expression, this latter positively correlated with p24 levels, was noted. Conclusions: VitD reduces HIV-1 infection in T cells possibly by inducing antiviral gene expression, reducing the viral co-receptor CCR5 and, at least at the highest cholecalciferol concentration, by promoting an HIV-1-restrictive CD38HLA-DR immunophenotype. |
publishDate |
2016 |
dc.date.issued.none.fl_str_mv |
2016 |
dc.date.accessioned.none.fl_str_mv |
2022-07-25T20:29:55Z |
dc.date.available.none.fl_str_mv |
2022-07-25T20:29:55Z |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
dc.type.local.spa.fl_str_mv |
Artículo de investigación |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.citation.spa.fl_str_mv |
Aguilar-Jiménez W, Villegas-Ospina S, González S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):497-506. doi: 10.1097/QAI.0000000000001150. |
dc.identifier.issn.none.fl_str_mv |
1525-4135 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/29861 |
dc.identifier.doi.none.fl_str_mv |
10.1097/QAI.0000000000001150 |
dc.identifier.eissn.none.fl_str_mv |
1944-7884 |
identifier_str_mv |
Aguilar-Jiménez W, Villegas-Ospina S, González S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):497-506. doi: 10.1097/QAI.0000000000001150. 1525-4135 10.1097/QAI.0000000000001150 1944-7884 |
url |
https://hdl.handle.net/10495/29861 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
J. Acquir. Immune Defic. Syndr. |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.format.extent.spa.fl_str_mv |
10 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Williams & Wilkins |
dc.publisher.group.spa.fl_str_mv |
Inmunovirología |
dc.publisher.place.spa.fl_str_mv |
Hagerstown, Estados Unidos |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/2/license_rdf https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/3/license.txt https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/1/AguilarWbeimar_2016_PrecursorFormsVitaminD.pdf |
bitstream.checksum.fl_str_mv |
b88b088d9957e670ce3b3fbe2eedbc13 8a4605be74aa9ea9d79846c1fba20a33 31bb0d1cdb0a23e71554efb1c791387c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173104873472000 |
spelling |
Aguilar Jiménez, WbeimarVillegas Ospina, SimónGonzález Díaz, Sandra MilenaZapata Builes, WildemanSaulle, IrmaGarziano, MicaelaBiasin, MaraClerici, MarioRugeles López, María Teresa2022-07-25T20:29:55Z2022-07-25T20:29:55Z2016Aguilar-Jiménez W, Villegas-Ospina S, González S, Zapata W, Saulle I, Garziano M, Biasin M, Clerici M, Rugeles MT. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):497-506. doi: 10.1097/QAI.0000000000001150.1525-4135https://hdl.handle.net/10495/2986110.1097/QAI.00000000000011501944-7884ABSTRACT: Background: Although the anti-HIV-1 effects of vitamin D (VitD) have been reported, mechanisms behind such protection remain largely unexplored. Methods: The effects of two precursor forms (cholecalciferol/calciol at 0.01, 1 and 100 nM and calcidiol at 100 and 250 nM) on HIV-1 infection, immune activation, and gene expression were analyzed in vitro in cells of Colombian and Italian healthy donors. We quantified levels of released p24 by enzyme-linked immunosorbent assay, of intracellular p24 and cell-surface expression of CD38 and HLA-DR by flow cytometry, and mRNA expression of antiviral and immunoregulatory genes by real-time reverse transcription-polymerase chain reaction. Results: Cholecalciferol decreased the frequency of HIV-1-infected p24CD4 T cells and levels of p24 in supernatants in a dose-dependent manner. Moreover, the CD4CD38HLA-DR and CD4CD38HLA-DR subpopulations were more susceptible to infection but displayed the greatest cholecalciferol-induced decreases in infection rate by an X4-tropic strain. Likewise, cholecalciferol at its highest concentration decreased the frequency of CD38HLA-DR but not of CD38HLA-DR T-cell subsets. Analyzing the effects of calcidiol, the main VitD source for immune cells and an R5-tropic strain as the most frequently transmitted virus, a reduction in HIV-1 productive infection was also observed. In addition, an increase in mRNA expression of APOBEC3G and PI3 and a reduction of TRIM22 and CCR5 expression, this latter positively correlated with p24 levels, was noted. Conclusions: VitD reduces HIV-1 infection in T cells possibly by inducing antiviral gene expression, reducing the viral co-receptor CCR5 and, at least at the highest cholecalciferol concentration, by promoting an HIV-1-restrictive CD38HLA-DR immunophenotype.COL001244410application/pdfengWilliams & WilkinsInmunovirologíaHagerstown, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Precursor forms of Vitamin D reduce HIV-1 infection in vitroVIH-1HIV-1ADP-Ribosil Ciclasa 1ADP-ribosyl Cyclase 1Vitamina DVitamin DLinfocitos TT-LymphocytesAntígenos HLA-DRHLA-DR AntigensCD38J. Acquir. Immune Defic. Syndr.Journal of Acquired Immune Deficiency Syndromes497506735CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53ORIGINALAguilarWbeimar_2016_PrecursorFormsVitaminD.pdfAguilarWbeimar_2016_PrecursorFormsVitaminD.pdfArtículo de investigaciónapplication/pdf996340https://bibliotecadigital.udea.edu.co/bitstream/10495/29861/1/AguilarWbeimar_2016_PrecursorFormsVitaminD.pdf31bb0d1cdb0a23e71554efb1c791387cMD5110495/29861oai:bibliotecadigital.udea.edu.co:10495/298612022-07-25 15:29:56.461Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |